Top Markets
Coin of the day
Sunshine Biopharma, Inc. Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc.

SBFM
Classificação em ações #39262
Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of... Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells. The company is also progressing SBFM-PL4, a compound under development as an anti-coronavirus treatment. In addition to its drug development, Sunshine Biopharma markets a range of nutritional products, such as the Essential 9 tablet and the Essential Calcium-Vitamin D supplement, alongside other scientifically formulated dietary aids. A collaboration with the University of Georgia supports the ongoing advancement of SBFM-PL4 as an anti-coronavirus agent. The firm's headquarters are situated in Pointe-Claire, Canada.
Preço da ação
$1.16
Última sincronização: 2026-07-31
Valor de mercado
$580.69K
Variação (1 dia)
-5.69%
Variação (1 ano)
-92.32%
País
US
Negociar Sunshine Biopharma, Inc. (SBFM)

Categoria

Histórico de preços das ações de Sunshine Biopharma, Inc. (SBFM)
Preço de fecho mais alto: $1.80 em 2026-07-01

Preço de fecho mais baixo: $5.00M em 2015-06-01
Histórico de preços das ações da Sunshine Biopharma, Inc. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -20.31%
2025 -53.17%
2024 -99.45%
2023 -62.36%
2022 -74.58%
2021 259.42%
2020 61.32%
2019 -97.23%
2018 -92.29%
2017 230.24%
2016 -13.88%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$171.67 -
DE
$161.38 24.85%
DE
$36.61 23.93%
JP
$225.65 39.11%
CH
$21.30 13.79%
IN